Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer.
- DOI
- 10.3390/cancers18071175
- Published
- 2026 Apr 7
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18071175,
title = {Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer.},
author = {Malko R and Shannon HE and Dobrota EA and Kreklau KE and Stevens LK and Jackson KW and Saadatzadeh MR and Pandya PH and Pollok KE},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18071175},
url = {https://doi.org/10.3390/cancers18071175}
}RIS
TY - JOUR TI - Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer. AU - Malko R AU - Shannon HE AU - Dobrota EA AU - Kreklau KE AU - Stevens LK AU - Jackson KW AU - Saadatzadeh MR AU - Pandya PH AU - Pollok KE PY - 2026 JO - Cancers DO - 10.3390/cancers18071175 UR - https://doi.org/10.3390/cancers18071175 ER -
APA
R, M., HE, S., EA, D., KE, K., LK, S., KW, J., MR, S., PH, P., & KE, P. (2026). Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer.. Cancers. https://doi.org/10.3390/cancers18071175
Source records
- pubmed · retrieved 2026-09-26T19:38:39.109Z